Potassium channel activator drugs: Mechanism of action, pharmacological properties, and therapeutic potential
- 1 March 1992
- journal article
- review article
- Published by Wiley in Medicinal Research Reviews
- Vol. 12 (2) , 73-148
- https://doi.org/10.1002/med.2610120202
Abstract
No abstract availableKeywords
This publication has 353 references indexed in Scilit:
- Lack of Effect of the Vasodilator Pinacidil on Insulin Secretion in Healthy HumansThe Journal of Clinical Pharmacology, 1990
- Comparative study of the effects of cromakalim (BRL 34915) and diazoxide on membrane potential, [Ca2+] i and ATP-sensitive potassium currents in insulin-secreting cellsThe Journal of Membrane Biology, 1990
- ATP-sensitive potassium channels in adult mouse skeletal muscle: Characterization of the ATP-binding siteThe Journal of Membrane Biology, 1989
- The gating of nucleotide-sensitive K+ channels in insulin-secreting cells can be modulated by changes in the ratio ATP4−/ADP3− and by nonhydrolyzable derivatives of both ATP and ADPThe Journal of Membrane Biology, 1988
- The potassium channel opener cromakalim (BRL 34915) activates ATP-dependent K+ channels in isolated cardiac myocytesBiochemical and Biophysical Research Communications, 1988
- Effects of pyridine nucleotides on the gating of ATP-sensitive potassium channels in insulin-secreting cellsThe Journal of Membrane Biology, 1988
- N″-cyano-N-4-pyridyl-N′-1,2,2-trimethylpropylguanidine, monohydrate (P 1134): A new, potent vasodilatorCellular and Molecular Life Sciences, 1980
- Electrophysiology and pharmacology of cardiac arrhythmias. VIII. Cardiac effects of diphenylhydantoin. BAmerican Heart Journal, 1975
- The effect of diazoxide on the veinsAmerican Heart Journal, 1972
- Insulinsekretion in vitroDiabetologia, 1966